PCA
CVS icon

Pallas Capital Advisors’s CVS Health CVS Stock Holding History

Pallas Capital Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.31M Sell
18,236
-4,001
-18% -$308K 0.05% 274
2025
Q4 		$1.76M Buy
22,237
+342
+2% +$27K 0.06% 240
2025
Q3 		$1.65M Buy
21,895
+3,308
+18% +$227K 0.06% 233
2025
Q2 		$1.28M Sell
18,587
-12,290
-40% -$806K 0.05% 276
2025
Q1 		$2.09M Buy
30,877
+20,480
+197% +$1.23M 0.09% 183
2024
Q4 		$467K Sell
10,397
-3,219
-24% -$181K 0.02% 374
2024
Q3 		$764K Buy
13,616
+6,158
+83% +$359K 0.03% 272
2024
Q2 		$447K Buy
7,458
+183
+3% +$11.4K 0.02% 328
2024
Q1 		$580K Sell
7,275
-836
-10% -$63.9K 0.02% 265
2023
Q4 		$640K Sell
8,111
-591
-7% -$42.1K 0.03% 239
2023
Q3 		$592K Sell
8,702
-75,675
-90% -$5.36M 0.04% 216
2023
Q2 		$6.01M Sell
84,377
-1,934
-2% -$138K 0.27% 53
2023
Q1 		$6.34M Buy
86,311
+5,991
+7% +$502K 0.59% 48
2022
Q4 		$6.99M Buy
80,320
+1,461
+2% +$141K 0.71% 39
2022
Q3 		$7.71M Buy
78,859
+1,716
+2% +$170K 0.86% 32
2022
Q2 		$7.26M Sell
77,143
-175
-0.2% -$17.1K 1% 21
2022
Q1 		$8.02M Buy
77,318
+649
+0.8% +$68.2K 1.02% 21
2021
Q4 		$7.79M Buy
76,669
+6,525
+9% +$603K 0.95% 21
2021
Q3 		$6.76M Buy
70,144
+21,884
+45% +$1.83M 0.74% 27
2021
Q2 		$3.94M Buy
48,260
+5,440
+13% +$445K 0.55% 47
2021
Q1 		$3.68M Buy
+42,820
New +$3.12M 0.82% 32

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pallas Capital Advisors's CVS Position: Q1 2026 in Review

Pallas Capital Advisors reduced its CVS Health (CVS) stake by 18% in Q1 2026, selling an estimated $308K and leaving 18,236 shares worth $1.31M. The position accounts for 0.05% of the portfolio, ranked #274.

Pallas Capital Advisors first reported a position in CVS in Q1 2021 and has held it in 21 quarters since. The position peaked at $8.02M in Q1 2022. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Pallas Capital Advisors held 18,236 shares of CVS Health worth $1.31M as of Q1 2026.
  • Pallas Capital Advisors sold 4,001 CVS Health shares in Q1 2026, an estimated $308K.
  • CVS Health made up 0.05% of Pallas Capital Advisors's portfolio in Q1 2026, its #274 holding.
  • Pallas Capital Advisors first reported a position in CVS Health in Q1 2021 and has held it in 21 quarters since.
  • Pallas Capital Advisors's CVS Health position peaked at $8.02M in Q1 2022.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Pallas Capital Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.